Re: repuplicans blamed for no electric cars
You've kinda lost me on how it is the Dem's fault, but I'm willing to listen. The legislation that has really allowed drug companies to fuck over consumers was bipartisan, and the intent was actually the exact opposite. The Hatch-Waxman Act, which was designed to streamline the process for bringing generic alternatives of branded drugs to market, has unintentionally allowed branded drug manufacturers to bottleneck the market and block the entry of generic drugs via a massive loophole.
Here's a real world example -- remember how post 9/11, there was all the concern about there being no inexpensive generic alternative for Cipro, the broad spectrum antibiotic used to treat anthrax exposure? Here's why: in 1991 a generic was poised to come to market. Bayer was able to delay their entry through the filing of patent infringement litigation before entering into an agreement with the would-be generic competitor in early 1997. Bayer paid $100M up front, and $25M per year, for the generic to not come to market. To the generic entrant, this is far more than they could ever hope to make selling the drug on the open market, but it preserves a $1B+/year revenue stream for Bayer, so it makes economic sense for them, too. Because of the way the regulatory scheme is set up, however, no generic can come to market until the first does, so the first entrant's agreement to refrain from selling the drug has the effect of preventing all generic competition.
Looking at Bush's track record on the issue, he has:
I'm not real sure what the dems could have done to help the pharma industry more than Bush has, particularly in light of the fact that republicans control both houses of congress and the executive branch, but I am sincerely curious to know what you are referring to. Lay it on me...
You've kinda lost me on how it is the Dem's fault, but I'm willing to listen. The legislation that has really allowed drug companies to fuck over consumers was bipartisan, and the intent was actually the exact opposite. The Hatch-Waxman Act, which was designed to streamline the process for bringing generic alternatives of branded drugs to market, has unintentionally allowed branded drug manufacturers to bottleneck the market and block the entry of generic drugs via a massive loophole.
Here's a real world example -- remember how post 9/11, there was all the concern about there being no inexpensive generic alternative for Cipro, the broad spectrum antibiotic used to treat anthrax exposure? Here's why: in 1991 a generic was poised to come to market. Bayer was able to delay their entry through the filing of patent infringement litigation before entering into an agreement with the would-be generic competitor in early 1997. Bayer paid $100M up front, and $25M per year, for the generic to not come to market. To the generic entrant, this is far more than they could ever hope to make selling the drug on the open market, but it preserves a $1B+/year revenue stream for Bayer, so it makes economic sense for them, too. Because of the way the regulatory scheme is set up, however, no generic can come to market until the first does, so the first entrant's agreement to refrain from selling the drug has the effect of preventing all generic competition.
Looking at Bush's track record on the issue, he has:
- Opposed legislation that would have closed the loophole that makes what I just mentioned possible
- Proposed immunity from personal injury claims for drugs that are FDA approved. Seems logical, right? Wrong. That a drug is FDA approved does not mean that it is safe, and you can find numerous examples of drugs that have been approved based upon information that was provided to the FDA that was either misleading, incomplete or flat out wrong -- fen-phen, serzone, baycol, to name a few
- Opposed efforts to allow people to purchase cheaper drugs from other countries -- although drug companies do a lot of nefarious things, I have never heard of them selling less safe versions of their drugs to other countries. They do, however, have different warnings in different countries. Compare the labels on drugs you get from different countries, and you will see different warnings -- drug companies do not warn people of harmful side effects because they want to, they do so because they are forced to, and they fight new warnings tooth and nail. The result is that depending upon what country you live in, you may or may not be warned about a harmful side effect or contraindication -- and the US is not the most strict, BTW, so if you buy a drug from a different country, you might learn about a potential hazard that the US label wouldn't mention
- Proposed a plan to assess the mental fitness of the youth of our country, citing concerns about teenage depression, etc. -- guess who will sponsor this plan? You got it -- the pharmaceutical industry. Golly, I wonder if that study will result in more prescriptions for antidepressants?
I'm not real sure what the dems could have done to help the pharma industry more than Bush has, particularly in light of the fact that republicans control both houses of congress and the executive branch, but I am sincerely curious to know what you are referring to. Lay it on me...
Comment